| |
| |
|
| Insider
Information: |
Squinto Stephen P |
| Relationship: |
Director, 10% Owner |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
238,160 |
|
|
Indirect Shares
|
6,290,493 |
|
|
| Direct
Value |
$19,437,710 |
|
|
|
Indirect Value
|
$19,013,945 |
|
|
| Total
Shares |
6,528,653 |
|
|
| Total
Value |
$38,451,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Global Ops.... |
2014-10-27 |
106,508 |
2013-10-28 |
104,186 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director, 10% Owner |
2022-05-19 |
131,652 |
2022-05-19 |
6,186,307 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-27 |
4 |
AS |
$188.36 |
$1,114,532 |
D/D |
(5,910) |
106,508 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-03 |
4 |
AS |
$169.95 |
$1,728,374 |
D/D |
(10,025) |
106,868 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-10 |
4 |
S |
$167.31 |
$273,552 |
D/D |
(1,635) |
101,308 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-09-24 |
4 |
S |
$159.50 |
$12,122 |
D/D |
(76) |
106,868 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-08-04 |
4 |
S |
$157.42 |
$261,632 |
D/D |
(1,662) |
106,944 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-03 |
4 |
S |
$157.14 |
$133,883 |
D/D |
(852) |
102,216 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$252,030 |
D/D |
(1,620) |
102,943 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
S |
$155.11 |
$589,418 |
D/D |
(3,800) |
94,818 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-04 |
4 |
S |
$153.63 |
$5,603,781 |
D/D |
(36,137) |
94,818 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-01-29 |
4 |
S |
$133.21 |
$149,039 |
D/D |
(1,118) |
103,068 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-10-28 |
4 |
S |
$124.06 |
$4,967,340 |
D/D |
(40,037) |
105,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-10-28 |
4 |
S |
$123.89 |
$123,890 |
I/I |
(1,000) |
104,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-11-04 |
4 |
AS |
$123.82 |
$1,749,664 |
D/D |
(14,125) |
104,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-07-12 |
4 |
AS |
$119.90 |
$2,158,200 |
D/D |
(18,000) |
108,462 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-08-05 |
4 |
S |
$116.87 |
$99,573 |
D/D |
(852) |
106,490 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-08-02 |
4 |
AS |
$114.95 |
$1,629,018 |
D/D |
(14,125) |
107,342 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-09-13 |
4 |
S |
$114.37 |
$114,370 |
I/I |
(1,000) |
105,490 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-09-24 |
4 |
S |
$112.54 |
$34,212 |
I/I |
(304) |
105,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2013-07-30 |
4 |
S |
$110.86 |
$124,163 |
D/D |
(1,120) |
107,342 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Research & Development |
• – – |
2012-07-27 |
4 |
AS |
$105.86 |
$10,800,149 |
D/D |
(100,668) |
86,994 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Research & Development |
• – – |
2012-07-31 |
4 |
AS |
$105.01 |
$106,585 |
D/D |
(1,015) |
85,979 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Research & Development |
• – – |
2012-07-09 |
4 |
AS |
$100.34 |
$5,021,772 |
D/D |
(50,000) |
87,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Research & Development |
• – – |
2011-03-02 |
4 |
S |
$99.11 |
$495,550 |
D/D |
(5,000) |
39,637 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Global Ops. Officer |
• – – |
2013-04-29 |
4 |
AS |
$98.96 |
$3,612,051 |
D/D |
(36,499) |
108,462 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Head of R&D |
• – – |
2013-02-04 |
4 |
S |
$95.66 |
$246,081 |
D/D |
(2,572) |
81,925 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
